Fenwal Overview

  • Year Founded
  • 1949

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 4,900

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Fenwal General Information

Description

Developer and manufacturer of blood transfusion systems. The company develops and markets products that collect, separate, process, filter, store, and administer whole blood and blood components for therapeutic use. It helps in the treatment of cancer, kidney failure, hemophilia, immune deficiencies, and infectious diseases. The company caters to blood centers, hospital blood banks, and plasma collection centers.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 3 Corporate Drive
  • Lake Zurich, IL 60047
  • United States
Primary Industry
Medical Supplies
Other Industries
Pharmaceuticals
Acquirer
Vertical(s)
Manufacturing, Oncology
Corporate Office
  • 3 Corporate Drive
  • Lake Zurich, IL 60047
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fenwal Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Fenwal‘s full profile, request access.

Request a free trial

Fenwal Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer and manufacturer of blood transfusion systems. The company develops and markets products that collect, separat
Medical Supplies
Lake Zurich, IL
4,900 As of 2012

Tourcoing, France
 

North Chicago, IL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Fenwal Competitors (4)

One of Fenwal’s 4 competitors is Macopharma, a Corporation company based in Tourcoing, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Macopharma Corporation Tourcoing, France
Abbott Corporation North Chicago, IL
The Zambon Group Private Debt Financed Bresso, Italy
TerumoBCT Formerly PE-Backed Lakewood, CO
To view Fenwal’s complete competitors history, request access »

Fenwal Patents

Fenwal Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4454673-A1 Bedside cell processing system having a reinfusion system Pending 27-Apr-2023
US-20240358907-A1 Bedside cell processing system having a reinfusion system Pending 27-Apr-2023
US-20240350360-A1 Plasma storage container Pending 24-Apr-2023
EP-4454629-A1 Plasma storage container Pending 24-Apr-2023
US-20240347147-A1 Device screen interaction using a scanner and bidirectional data transfer Pending 12-Apr-2023 G16H10/40
To view Fenwal’s complete patent history, request access »

Fenwal Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fenwal Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Fenwal‘s full profile, request access.

Request a free trial

Fenwal FAQs

  • When was Fenwal founded?

    Fenwal was founded in 1949.

  • Where is Fenwal headquartered?

    Fenwal is headquartered in Lake Zurich, IL.

  • What is the size of Fenwal?

    Fenwal has 4,900 total employees.

  • What industry is Fenwal in?

    Fenwal’s primary industry is Medical Supplies.

  • Is Fenwal a private or public company?

    Fenwal is a Private company.

  • What is the current valuation of Fenwal?

    The current valuation of Fenwal is .

  • What is Fenwal’s current revenue?

    The current revenue for Fenwal is .

  • Who are Fenwal’s investors?

    Baxter International, Maverick Ventures, and TPG have invested in Fenwal.

  • Who are Fenwal’s competitors?

    Macopharma, Abbott, The Zambon Group, and TerumoBCT are competitors of Fenwal.

  • When was Fenwal acquired?

    Fenwal was acquired on 14-Dec-2012.

  • Who acquired Fenwal?

    Fenwal was acquired by Fresenius Kabi.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »